Advertisement
  • Finding Answers in Prostate Cancer

    PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.

    by Sandra Gordon

  • Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?

    Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.

    by Myles Starr

  • Germline Genetic Testing Lags Behind Guidelines

    Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.

    by Jon Kelvey

  • Progress in Lung Cancer 

    November is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.

  • Against All Odds

    At age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.

    by Karon Warren

  • Finding the ‘Silent Killer’

    Strange symptoms led cancer care nurse Eve Spiegel to an ovarian cancer diagnosis.

    by Eve Spiegel

  • Making Treatment Decisions

    It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.

    by Abigail M. Johnston

  • Forward Look

    The Promise of Liquid Biopsies

    Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.

    by Tara Haelle

  • Forward Look

    The Chemotherapy Choice

    Adding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.

    by Kris Conner

  • Forward Look

    Tissue-sparing Surgery

    A clinical trial affirms the value of a procedure that preserves more tissue in early-stage lung cancer patients.

    by Ashley P. Taylor